ExpandAmong patients newly diagnosed with Parkinson’s disease, 90.2% were aged 60 or older at diagnosis, with a median diagnosis age of 73. Diagnoses before age 50 were rare, accounting for 2.6% of patients.
ExpandAmong patients newly diagnosed with Parkinson’s disease, 90.2% were aged 60 or older at diagnosis, with a median diagnosis age of 73. Diagnoses before age 50 were rare, accounting for 2.6% of patients.
ExpandUnder the 2026 cholesterol treatment guideline, 54.6% of adults aged 20–79 without established cardiovascular disease were eligible for lipid-lowering therapy, compared with 41.3% under the 2018 guideline, a 13.3 percentage-point increase in the treatment-eligible share.
ExpandAmong women seen in outpatient care, the rate of hormone therapy (HT) use rose from 1.7% in January 2017 to 3.6% in April 2026, a near-doubling. The increase was modest through 2022 and then accelerated sharply from 2023 onward.
ExpandThe share of male patients prescribed testosterone fell from 0.83% in 2013 to 0.64% by 2021. It then rose to 0.93% in 2025 and reached 0.95% in the partial first half of 2026.
ExpandThe share of male patients prescribed testosterone fell from 0.83% in 2013 to 0.64% by 2021. It then rose to 0.93% in 2025 and reached 0.95% in the partial first half of 2026.
ExpandAmong patients newly eligible for cancer screening, those diagnosed with autism had a 35.6% lower likelihood of on-time screening overall compared to patients without autism. The gap was largest for cervical (50.7% lower likelihood) and breast (28.7% lower likelihood) cancer screening, and smaller but still significant for prostate cancer screening (14.9% lower likelihood).
ExpandAmong patients newly eligible for cancer screening, those diagnosed with autism had a 35.6% lower likelihood of on-time screening overall compared to patients without autism. The gap was largest for cervical (50.7% lower likelihood) and breast (28.7% lower likelihood) cancer screening, and smaller but still significant for prostate cancer screening (14.9% lower likelihood).
ExpandCOVID-19 visits fell to the lowest level of the post-pandemic era the week of June 14, 2026, reaching 48.5 encounters per 100,000 patients, roughly one-third of the prior seasonal lows seen in spring 2024 (~177 per 100,000) and spring 2025 (~156 per 100,000).
ExpandCOVID-19 visits fell to the lowest level of the post-pandemic era the week of June 14, 2026, reaching 48.5 encounters per 100,000 patients, roughly one-third of the prior seasonal lows seen in spring 2024 (~177 per 100,000) and spring 2025 (~156 per 100,000).
ExpandConcussion diagnoses among children show a strong seasonal pattern that is most pronounced in older adolescent age groups. Among children aged 14–18, the 2025 monthly rate peaked in October at 1,105 per 100,000 compared to 331 per 100,000 in July.
ExpandConcussion diagnoses among children show a strong seasonal pattern that is most pronounced in older adolescent age groups. Among children aged 14–18, the 2025 monthly rate peaked in October at 1,105 per 100,000 compared to 331 per 100,000 in July.
ExpandMale patients aged 10 to 15 who had an ED visit for a motor vehicle crash (MVC) were as much as four times as likely to experience a subsequent firearm injury compared with those whose ED visit was for a fall, in some parts of the United States.
ExpandThe risks of myocardial infarction (MI), ischemic stroke, and hemorrhagic stroke are increased for patients with high or low average systolic blood pressure (BP). The risks are greater at very low systolic BP than at very high systolic BP.
ExpandAt 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
ExpandMale patients aged 10 to 15 who had an ED visit for a motor vehicle crash (MVC) were as much as four times as likely to experience a subsequent firearm injury compared with those whose ED visit was for a fall, in some parts of the United States.
ExpandThe risks of myocardial infarction (MI), ischemic stroke, and hemorrhagic stroke are increased for patients with high or low average systolic blood pressure (BP). The risks are greater at very low systolic BP than at very high systolic BP.
ExpandAt 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
ExpandOne-third of suzetrigine prescriptions (33.0%) were written in encounters with a diagnosis of chronic pain, compared with 6.7% of opioid prescriptions. Opioids were most often prescribed during encounters with evidence of surgery (48.8%) and acute pain (19.8%) compared to 10.2% and 31.8%, respectively, for suzetrigine.
ExpandMale patients aged 10 to 15 who had an ED visit for a motor vehicle crash (MVC) were as much as four times as likely to experience a subsequent firearm injury compared with those whose ED visit was for a fall, in some parts of the United States.
ExpandThe risks of myocardial infarction (MI), ischemic stroke, and hemorrhagic stroke are increased for patients with high or low average systolic blood pressure (BP). The risks are greater at very low systolic BP than at very high systolic BP.
ExpandAt 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
